Hinge Health Class A (HNGE) closed at $115.98 on November 5, 2026, down 4.0% from the previous close, on volume of 1,354,743 shares (30-day average 1,930,871).
Data as of November 5, 2026.
Hinge Health’s Strong Q3 and Raised 2026 Outlook Reinforce Growth Momentum
TipRanks (Wed, 4-Nov 11:55 AM ET)
Hinge Health Earnings Call Highlights Growth and Momentum
TipRanks (Tue, 3-Nov 7:26 PM ET)
TipRanks (Tue, 3-Nov 1:10 PM ET)
Hinge Health: Strong Growth and Expanding Profitability Drive Price Target Raise to $131
TipRanks (Tue, 3-Nov 7:47 AM ET)
TipRanks (Tue, 3-Nov 5:31 AM ET)
Hinge Health Reports Record Third-Quarter Results and Growth
TipRanks (Mon, 2-Nov 4:39 PM ET)
Hinge Health, Inc. Non-GAAP EPS of $0.71 beats by $0.11, revenue of $235B beats by $234.78B
Seeking Alpha News (Mon, 2-Nov 4:27 PM ET)
Hinge Health reports record third quarter 2026 financial results
Business Wire (Mon, 2-Nov 4:05 PM ET)
Here are the major earnings after the close Monday
Seeking Alpha News (Mon, 2-Nov 9:00 AM ET)
Hinge Health to announce third quarter 2026 financial results on November 2, 2026
Business Wire (Mon, 5-Oct 12:00 PM ET)
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
Hinge Health Class A trades on the NYSE stock market under the symbol HNGE.
As of November 5, 2026, HNGE stock price declined to $115.98 with 1,354,743 million shares trading.
HNGE has a beta of 1.47, meaning it tends to be more sensitive to market movements. HNGE has a correlation of 0.07 to the broad based SPY ETF.
HNGE has a market cap of $8.97 billion. This is considered a Mid Cap stock.
Last quarter Hinge Health Class A reported $235 million in Revenue and $.66 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.13.
The top ETF exchange traded funds that HNGE belongs to (by Net Assets): VTI, IWM, VB, VXF, IWO.
HNGE has outperformed the market in the last year with a price return of +117.0% while the SPY ETF gained +9.7%. HNGE has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +46.0% and +3.6%, respectively, while the SPY returned -4.7% and -5.2%, respectively.
HNGE support price is $117.27 and resistance is $124.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HNGE shares will trade within this expected range on the day.
